Improved molecular typing assay for rhinovirus species...
-
Upload
nguyentruc -
Category
Documents
-
view
215 -
download
2
Transcript of Improved molecular typing assay for rhinovirus species...
Improved molecular typing assay for rhinovirus species
A, B and C
Yury A. Bochkov, Kristine Grindle, Fue Vang, Michael D. Evans, and James E. Gern
Online supplemental materials
Table of Contents
Supplementary Fig. S1. Neighbor-joining phylogenetic tree based on partial 5’-UTR nucleotide sequences of RV-A, RV-B and RV-C types (n = 156) constructed using MEGA software (MEGA 5.1). Supplementary Fig. S2. Cross-reactivity of novel “species-specific” primers targeting 5’-UTR.
Supplementary Fig. S3. Cross-reactivity of the novel “species-specific” primers targeting 5’- UTR is not completely eliminated by ExoSAP treatment of the first PCR products. Supplementary Fig. S4. Sensitivity of the original and modified PCR assays targeting 5’-UTR. Supplementary Fig. S5. Chromatograms generated by direct sequencing of the PCR product of RV-A57 clinical isolate using (A) original P3 or (B) new 5’UTR-revseq primer in SeqMan software (DNAStar, USA). Supplementary Fig. S6. Pairwise nucleotide p-distances between reference strains representing all known types of RV-A, RV-B and RV-C (intertype variability) for partial 5’UTR (A) and VP4/VP2 (B) regions calculated using MEGA software (MEGA 5.1). Supplementary Fig. S7. Neighbor-joining phylogenetic tree based on partial 5’UTR nucleotide sequences of RV-A, RV-B and RV-C types (n = 156) and W types (n = 59) constructed using MEGA software (MEGA 5.1). Supplementary Fig. S8. Neighbor-joining phylogenetic tree based on partial VP4/VP2 nucleotide sequences of RV-A, RV-B and RV-C types (n = 174) and W types (n = 58) constructed using MEGA software (MEGA 5.1). Supplementary Fig. S9. Summary of the clinical samples and RV isolates used for modification and validation of the molecular typing assay. Supplementary Tables 1–4. Supplementary Methods.
RV
-A11
RV
-A10
4 JX
1937
97R
V-A2
4
94
RV-
A90
91
RV-
A20
RV-
A68
97
81
RV-
A76
RV-
A33
RV-
A34
RV-
A18
RV-
A46
RV-A
08RV
-A95
99 RV-A
80RV
-A21
RV-A
50RV
-A59
RV-A6
3
99
87
RV-A10
RV-A31
RV-A47
99
RV-A10
0
RV-A56
RV-A66
RV-A77
74
98
RV-A57
RV-A105 JN614995
99
RV-A28
RV-A53
98
RV-A40
RV-A85
99
RV-A38
RV-A54
RV-A9899
RV-A25
RV-A6299
RV-A29
RV-A449978
94
RV-A39RV-A02RV-A4976
RV-A23RV-A30
83
RV-A60RV-A09RV-A32RV-A67
8796
93
RV-A15RV-A7499
70
RV-A55RV-A16RV-A81
9798
98
RV-A64RV-A94
97
RV-A82RV-A22
99
RV-A43RV-A75
93
RV-A01
88
RV-A19RV-A61
RV-A96
98
RV-A73
RV-A13
RV-A41
98
78
95
94
99
RV-A12
RV-A45
76
RV-A78
RV-A101 GQ415051
99
RV-C32 JN798581
RV-C39 JN205461
99RV-C13 HM
581812
75
RV-C43 JX074056
RV-C22 JN621242
RV-C
7 DQ
875932
RV-C
21 HM
581807
99R
V-C10 G
Q323774
RV-C
3 EF186077
RV-C
1 EF077279
RV-C
6 EF58238799
7499
99
RV-A07
RV-A88
90
RV
-A58
RV
-A3698
A-V
R29
9699
99
RV
-A65
RV-
A102
EF1
5542
199
RV-
A51
93
RV-
A103
JF9
6551
5
83
RV-
A71
RV-
A106
JX0
2555
5
99
99
RV-
C18
HM
5818
22
RV-
C28
HM
5818
59
84
RV-
C8
GQ
2232
27
73
RV-
C16
HM
5818
48
RV-C
17 H
M58
1840
99
99
RV-C
12 J
F317
017
RV-C
31 H
M58
1869
RV-C
42 J
Q99
4500
8699
99
RV-C
24 H
M58
1843
RV-C
25 JF
3170
13
99
RV-C15
GU21
9984
RV-C23
HM58
1805
87
RV-C30
HM58
1862
RV-C41
JN79
8565
99
RV-C2 E
F0772
80
RV-C40
JQ24
5963
RV-C5 EF582386
RV-C11 EU840952
RV-Cpat24 FJ200456
9999 99
95
RV-C4 EF582385
RV-C49 JN798566
99 99
RV-B17RV-B70 82RV-B91 99RV-B48RV-B52RV-B104 FJ445137
98 97RV-B69 99RV-B26RV-B42RV-B05
RV-B9973
95 99RV-B84RV-B86RV-B83RV-B92
75RV-B35RV-B79
99
RV-B04RV-B97
95
RV-B27
RV-B9386
RV-B03
RV-B37
RV-B06
RV-B103 JN798572
89
RV-B101 JF781501
RV-B102 JX074053
RV-B14
RV-B72
82
96
99
83
99
90
RV-C51 JF317015
RV-C51 JX291115
90
RV-C26 HM581808
99
RV-C36 JN541267
RV-C46 HM581884
79
98
RV-C9 GQ223228
RV-C14 HM581815
RV-C33 HM581838
99
RV-C50 JF317005
73
RV-C35 JF436925
RV-C19 EU840728
RV-C20 HM581870
RV-C27 HM581810
82
RV-C29 HM581853
RV-C45 JN837686
7199
9280
99
PV-1mC
V-A1399
PV-3l
99
90
0.00
0.05
0.10
0.15
Supplementary Fig. S1. Neighbor-joining phylogenetic tree based on partial 5’UTR nucleotide sequences of RV-A, RV-Band RV-C types (n=156) constructed using MEGA software (MEGA 5.1). All major nodes are labeled with bootstrap values(% of 500 replicates). RV-A and RV-B reference strain accession numbers correspond to those published previously(Palmenberg et al., 2009). Accession numbers of RV-C types and novel RV-A and RV-B types are shown. Branch lengthsare proportional to nucleotide similarity (p distance). Human enteroviruses (HEV) are included as an outgroup.
HEV
5’-UTR(~300 bp)
n=156 types
RV-ARV-Ca
RV-CcRV-B
L 1 2 3 4 5 6 7 8 9 10 L 11 12 13 14 15 16 17 18 19 20
Supplementary Fig. S2. Cross-reactivity of the redesigned forward primers targeting 5’-UTR. A total of 20 clinical samples(nasal secretions) containing 5 different types of RV-A (1-5), RV-B (6-10), RV-Ca (11-15) and RV-Cc (16-20) were testedby PCR using previously reported P1 and P3 primers in 1st reaction (A), and then reamplified using either the sameprimers, or novel 5’-UTRn-A, B and C primers, alone or combined in 2nd reaction (B-E). L is 1kb Plus DNA ladder (LifeTechnologies).
A
B
C
D
negative controls
RV-A RV-B RV-Ca RV-Cc
1 2 3 4 5 L 1 2 3 4 5 1 2 3 4 5 L 1 2 3 4 5 1 2 3 4 5 L
5’UTRn-AP1+P3 5’UTRn-B 5’UTRn-C 5’UTRn-A,B,C
6 7 8 9 10 L 6 7 8 9 10 6 7 8 9 10 L 6 7 8 9 10 6 7 8 9 L 10
11 12 13 14 15 L 11 12 13 14 15 11 12 13 14 15 L 11 12 13 14 15 11 12 13 14 15
E
RV species:Clinicalsamples:
Primers:Clinicalsamples:
16 17 18 19 20 L 16 17 18 19 20 16 17 18 19 20 L 16 17 18 19 20 16 17 18 19 20
L 1 2 3 4 5 1 2 3 4 5 1 2 3 4 5 L 1 2 3 4 5 1 2 3 4 5
5’UTRn-AP1+P3 5’UTRn-B 5’UTRn-C 5’UTRn-A,B,CPrimers:Clinicalsamples:
6 7 8 9 10 6 7 8 9 10 6 7 8 9 10 L 6 7 8 9 10 6 7 8 9 10
Supplementary Fig. S3. Cross-reactivity of the redesigned forward primers targeting 5’-UTR is not completelyeliminated by ExoSAP treatment of the 1st PCR products. RV-A (1-5) and RV-B (6-10) 1st PCR products (SupplementaryFig. 3A) were treated with exonuclease I and shrimp alkaline phosphatase (ExoSAP) mix, and then reamplified usingeither the same primers, or novel 5’-UTRn-A, B and C primers, alone or combined in 2nd reaction. L is 1kb Plus DNAladder (Life Technologies).
- Ctrls L A11 B97 C5 C26 A78 B6 A75 -
A
B
RV type:
PCR mix:(2nd rxn)
Platinum
L A11 B97 C5 C26 A78 B6 A75 -
GoTaq Green
- Ctrls L A11 B97 C5 C26 A78 B6 A75 - L A11 B97 C5 C26 A78 B6 A75 -
C
104 10-1 104 10-1 104 10-1 104 10-1
105 10-1 105 10-1 105 10-1 105 10-1
RV-
A16
RV-
B14
RV-
C15
P1+P3 5’UTRn-A,B,C+5’UTR-rev5’UTRn-A,B,C+5’UTR-rev
D
390 bp
390 bp
Supplementary Fig. S4. Sensitivity of the original and modified PCR assays targeting 5’-UTR. Second PCR products obtained using Platinum PCR Supermix, High Fidelity (Life Technologies) and GoTaq Green Master Mix (Promega) with original (A) or modified (B) assay. A total of seven RV positive samples containing RV-A, B or C clinical isolates and one RV negative sample (-) producing human sequence amplicon were tested. (C) Products obtained after the first PCR amplification using original or modified primers. (D) Re-amplification of the first PCR products obtained with original (left panel) or modified (right panel) primers using modified primers in second PCR. Serial 10-fold dilutions (from 104–105 PFU to 10-1 PFU) of representative strains of RV-A, B or C were tested. L is 1kb Plus DNA ladder (Life Technologies).
10 20 30 40 50 60 70 80 90 100 110
ATATGGCTTCACACCCGTAAGGGTGTGCAGGCAGCCACGCAGGCTAGAACACTGTCGCCAGNGGGGGTCTTCTAGCCTCATCTGCCAGGTCTACTGTGGGGTTCAGCGGAGCGA
120 130 140 150 160 170 180 190 200 210 220
CCAACCATAGGCTCTCAAAGATGGTACTAANCTTTGCGTAGGCACTTTGCGNATAACGATCTAAGTTGTTTTTGCCCTGTTGGAGCATATCAACTTTGACCGGTGA
B
A
Supplementary Fig. S5. Chromatograms generated by direct sequencing of the PCR product of RV-A57 clinical isolate using (A) original P3 or (B) new 5’UTR-revseq primer in SeqMan software (DNAStar, USA). Undetermined bases (N) are boxed.
10 20 30 40 50 60 70 80 90 100 110
ATATGGCTTCACACCCGTAAGGGTGTGCAGGCAGCCACGCAGGCTAGAACACTGTCGCCAGTGGGGGTCTTCTAGCCTCATCTGCCAGGTCTACTGTGGGGTTCAGCGGAGCGA
120 130 140 150 160 170 180 190 200 210 220
CCAACCATAGGCTCTCAAAGATGGTACTAAGCTTTGCGTAGGCACTTTGCGGATAACGATCTAAGTTGTTTTTGCCCTGTTGGAGCATATCAACTTTGACCGGGGA
RV-A (n=83)
0
50
100
150
200
250
300
0 0.05 0.1 0.15 0.2 0.25 0.3
RV-B (n=29)
0
10
20
30
40
50
60
0 0.05 0.1 0.15 0.2 0.25
Supplementary Figure S6. Pairwise nucleotide p-distances between reference strains representing all knowntypes of RV-A, RV-B and RV-C (intertype variability) for partial 5’UTR (A) and VP4/VP2 (B) regions calculated using MEGA software (MEGA 5.1).
5’UTR
RV-A (n=83)
0
100
200
300
400
500
600
700
0 0.05 0.1 0.15 0.2 0.25
RV-B (n=30)
0102030405060708090
0 0.05 0.1 0.15 0.2 0.25
VP4/VP2
nucleotide p-distance nucleotide p-distance
RV-C (n=64)
0
50
100
150
200
250
300
350
0 0.05 0.1 0.15 0.2 0.25 0.3 0.35
nucleotide p-distance
RV-C (n=47)
0102030405060708090
100
0 0.05 0.1 0.15 0.2 0.25 0.3 0.35 0.4
nucleotide p-distance
nucleotide p-distance nucleotide p-distance
A
B
RV
-A11
RV
-A10
4 JX
1937
97R
V-A
24
94
RV
-A90
89
RV
-A20
RV-A
6896
80
RV-A
76RV
-A33
RV-A
34RV
-A18
RV-A
46W
48 (R
V-A
*)
7078
RV-A
08RV
-A95
99 RV-A
21RV
-A80
90
RV-A50
W49
(RV-A
*)
RV-A59
RV-A63
99
80
RV-A57
RV-A105 JN
614995
99 RV-A39
RV-A15
RV-A74
99
99
99 W14 (RV-A68/C3)*
RV-C13 HM581812
W07 (RV-C13)99
RV-C32 JN798581
W58 (RV-C32)99
RV-C39 JN205461
W27 (RV-C39)99
99
RV-A45RV-A12
84
RV-A78RV-A101 GQ415051W28 (RV-A101)
9999
RV-C43 JX074056W36 (RV-C43)
99
RV-C21 HM581807W29 (RV-C21)
96
RV-C7 DQ875932
99
RV-C22 JN621242W15 (RV-C22)
99
78
RV-C3 EF186077W02 (RV-C3)
99
RV-C10 GQ323774
W55 (RV-C10)
99
RV-C1 EF077279
W56 (RV-C1)
99
RV-C6 EF582387
W24 (RV-C6)
85
81
99
78
99
76
97
71
W22 (RV-A*)
RV-A07
RV-A88
91
RV-A58
RV-A36
RV-A89
9496
84
99
99
RV-A65
RV-A102 EF155421
99RV-A51
93
RV-A103 JF965515
W06 (RV-A103)
99
91
RV-A
71
RV-A
106 JX025555
W53 (R
V-A
106)
99
9999
W47 (RV
-Cpat28)
W47-R
954 (RV
-C8)
82
RV-C8 G
Q223227
99
W59 (R
V-C
pat28)99
RV
-C18 H
M581822
W08 (R
V-C
18)99
RV
-C28 H
M581859
W20 (R
V-C
28)99
93
90
848185M
H 61C-
VR
W38
(RV
-C16
)99
RV
-C17
HM
5818
40
W57
(RV
-C17
)99
9999
RV
-C12
JF31
7017
W09
(RV
-C12
)
97
W04
(RV
-C44
)
99
RV-C
31 H
M58
1869
W30
(RV
-C31
)
99
RV-C
42 JQ
9945
00
W16
(RV
-C42
)99
80
99
99
RV-C
24 H
M58
1843
W34
(RV-
C24)
99
RV-C
25 JF
3170
13
W05
(RV-
C25)
99
99
RV-C
15 G
U2199
84
W10
(RV-C
15)
99
RV-C23
HM
5818
05
W17
(RV-C
23)
99
86
RV-C30
HM
5818
62
W42
(RV-C
30) 99
RV-C41
JN79
8565
* W25
(RV-C
41)
99
99
80
RV-C2 EF077280
W12 (RV-C2)
99
W39 (RV-C47)
RV-C40 JQ245963
W11 (RV-C40) 99
RV-C5 EF582386
W46 (RV-C5) 99
RV-C11 EU840952
RV-Cpat24 FJ200456W23 (RV-C11)
9999
98
99 95
RV-C4 EF582385RV-C49 JN798566
W33 (RV-C49)99
99
99
RV-B 85
RV-C51 JF317015W32 (RV-C37) 99
RV-C51 JX29111577
RV-C26 HM581808
W37 (RV-C26) 99
98
W26 (RV-Cpat10)
RV-C46 HM581884
W19 (RV-C46)
99
W52 (RV-Cpat21)
RV-C36 JN541267
W01 (RV-C36)99
99
80
97
RV-C9 GQ223228
W31 (RV-C9)99
RV-C33 HM581838
W54 (RV-C33)
98
W21 (RV-Cpat22)
98
RV-C14 HM581815
W03 (RV-C14)99
98
W51 (RV-Cpat22)
99
W43 (RV-C50)
W18 (RV-Cpat19)
RV-C35 JF436925
W40 (RV-C35)
99
99
88
RV-C19 EU840728
W41 (RV-C19)
99
RV-C27 HM581810
W44 (RV-C27)
99
RV-C29 HM581853
W45 (RV-C29)
99
W35 (RV-Cpat17)
83
RV-C20 HM581870
W50 (RV-C34)
99
RV-C45 JN837686
W13 (RV
-C45)99
7299
97
71
99
EV
85
0.00
0.05
0.10
0.15
5’-UTR(~300 bp)
RV-ARV-Ca
RV-Cc
R
R
R
R
Supplementary Fig. S7. Neighbor-joining phylogenetic tree based on partial 5’UTR nucleotide sequences of RV-A, RV-Band RV-C types (n=156) and Wisconsin (W) isolates (n=59) constructed using MEGA software (MEGA 5.1). All major nodesare labeled with bootstrap values (% of 500 replicates). All RV-B and some RV-A branches that do not contain novel types werecondensed for simplicity. RV-A reference strain accession numbers correspond to those published previously (Palmenberget al., 2009). Accession numbers of RV-C types and newly identified RV-A types are shown. Branch lengths are proportional tonucleotide similarity (p-distance). Human enteroviruses (HEV) are included as an outgroup. W types are followed bycorresponding RV-A or RV-C type designations based on VP4/VP2 partial sequences (http://www.picornastudygroup.com).Novel W types (W53-59) are shown in bold; putative recombinant W types (R) are underlined. Putative artificial recombinantW14, misidentified W25 (RV-C41) and three novel RV-A types (W22, W48 and W49) are labeled by star sign.
RV
-C2
W12
99
RV
-C40
W11
99
92
RV
-C47
W39
99
72
RV-C
pat
18RV
-C35
W40
99
RV-C
pat
19W
18
99
97
84
RV-C
14W
03
99
RV-C
33
W54
99 RV-C
48W
51RV-C
pat22
W21
(C33
)
98
99
7999
RV-C4
RV-C49
W33
99
99
89
RV-C41
W25
92
RV-C pat20
97
RV-C30
W42
99
99
RV-C19
W41
99 RV-C24
W34
99 RV-C25
W05
99
7990
RV-C23
W1799
RV-C51 JX291115
RV-C15W10
998999
RV-C12W0999
RV-C44W04
99 RV-C42W1699
95
RV-C16W38
99
RV-C17W5799
99
RV-C31W30
99RV-C pat28W47 (C8)W59
99
RV-C8W47-R954
99
99
RV-C18W08
99
RV-C pat27RV-C pat24
RV-C28W20
99
99
99
98
98
86
RV-C26W37
99
RV-C37W32 (C51)
99
81
RV-C51
RV-C51 JF317015
99
92
RV-C46W19
99RV-C36W
01
99RV-Cpat21
W52
99
9898
RV-C9W31
99RV-C50
W43
99RV
-C34
W50 (C20)
99RV
-C20
99RV
-C29W
4599
RV-C pat17
W35
99R
V-C
45W
1399
99
RV
-C27
W44
99
RV
-C5
W46
99
RV
-C38
RV
-C11
W23 (C
pat24)
9988
87
97
9985
75
RV-C
pat
10
W26
99
RV-C
1
W56
99
RV-C
pat
14
RV-C
pat
16
99
RV-C
3
W02
99
RV-C
6
W24
99
93
RV-C
10
W55
99
99
RV-C22
W15
99
RV-C13
W07
99
RV-C32
W58
99
RV-C39
W27
9999
RV-C43W36
99RV-C7RV-C21W29
9990 96
99 99
RV-A78RV-A65
RV-A102 EF15542192
RV-A51
95
RV-A71RV-A106 JX025555W53
99 94
RV-A103 JF965515W0699RV-A45
RV-A08RV-A95 99 96RV-A36RV-A58RV-A89
99
RV-A88W22
82
RV-A07
98
RV-A46
RV-A80
W48
97
RV-A53
RV-A101 GQ415051
W2899
RV-A28
70
RV-A31
RV-A47
99
W49
RV-A56
RV-A33
RV-A43
RV-A38RV-A60
9593
92
79
99
86
RV-B
EV
86
0.00
0.05
0.10
0.15
0.20
VP4-VP2(252-258 bp)
RV-A
RV-C
R
R
R
R
Supplementary Fig. S8. Neighbor-joining phylogenetic tree based on partial VP4/VP2 nucleotide sequences of RV-A, RV-Band RV-C types (n=174) and Wisconsin (W) isolates (n=58) constructed using MEGA software (MEGA 5.1). All major nodesare labeled with bootstrap values (% of 500 replicates). All RV-B and some RV-A branches that do not contain novel types werecondensed for simplicity. RV-A reference strain accession numbers correspond to those published previously (Palmenberget al., 2009), RV-C types are designated according to the proposed molecular classification by Simmonds et al, (2010) and McIntyre et all, (2013). Accession numbers of RV-C51 putative recombinant sequences and novel RV-A types are shown.Branch lengths are proportional to nucleotide similarity (p-distance). Human enteroviruses (HEV) are included as anoutgroup. The majority of W types cluster with corresponding RV-C reference types (http://www.picornastudygroup.com).Novel W types (W53-59) are shown in bold; putative recombinant W types (R) are underlined and followed by RV-C type(shown in parenthesis) that revealed the highest identity by 5’UTR partial sequence.
Supplementary Fig. S9. Summary of the clinical samples and RV isolates used for modification and validation of the molecular typing assay.
n = 3028 clinical samplesfrom 310 children
RV negative(n = 1913)
RV positive (37%)(n = 1115)
RV-A (66 types)n = 604
RV-B (16 types)n = 209
RV-C (42 types)n = 213
Multiple RV types(n = 89)
RhinoGen study samples
Viral sinusitis study samples
n = 785 clinical samplesfrom 142 children
RV negative(n = 619)
RV positive (21%)(n = 166)
RV-A (31 types)n = 92
RV-B (6 types)n = 10
RV-C (30 types)n = 62
Multiple RV types(n = 2)
Sample RV type Primer Length (bp) q>=40(q/bplength)x100
q>=30(q/bplength)x100
q>=20(q/bplength)x100
1 A57 P3 145 80 55 114 79 132 912 C6 P3 147 73 50 102 69 125 853 B35 P3 144 7 5 37 26 82 574 C46 P3 152 69 45 106 70 132 875 C44 P3 151 101 67 137 91 149 996 B83 P3 141 4 3 11 8 47 337 A75 P3 147 18 12 64 44 125 858 C15 P3 147 12 8 61 41 114 789 A59 P3 145 25 17 66 46 111 77
1 A57 5'UTR-revseq 145 142 98 143 99 144 992 C6 5'UTR-revseq 147 66 45 110 75 139 953 B35 5'UTR-revseq 144 89 62 131 91 144 1004 C46 5'UTR-revseq 152 146 96 152 100 152 1005 C44 5'UTR-revseq 152 31 20 72 47 116 766 B83 5'UTR-revseq 143 143 100 143 100 143 1007 A75 5'UTR-revseq 147 141 96 145 99 146 998 C15 5'UTR-revseq 147 134 91 145 99 147 1009 A59 5'UTR-revseq 145 105 72 135 93 141 97
Supplementary Table S1. Assessment of the quality of nucleotide sequences obtained by directsequencing of the PCR products of nine RV clinical isolates with P3 or 5’UTR-revseq primersimplemented by Phred. Quality scores (q) for each sequence fragment assigned to each base arelogarithmically linked to error probability.
Partial 5'UTR Partial VP4/VP2HRV type 1 HRV type 2 P-distance HRV type 1 HRV type 2 P-distance
1 RV-A08 RV-A95 0.00 1 RV-A08 RV-A95 0.012 RV-A29 RV-A44 0.02 2 RV-A29 RV-A44 0.053 RV-A25 RV-A62 0.02 3 RV-A25 RV-A62 0.074 RV-A65 RV-A102 0.03 4 RV-A31 RV-A47 0.075 RV-A54 RV-A98 0.03 5 RV-A20 RV-A68 0.096 RV-A31 RV-A47 0.04 6 RV-A65 RV-A102 0.107 RV-A59 RV-A63 0.04 7 RV-A24 RV-A104 0.108 RV-A11 RV-A104 0.05 8 RV-A23 RV-A30 0.109 RV-A15 RV-A74 0.05 1 RV-B05 RV-B99 0.10
10 RV-A32 RV-A67 0.05 2 RV-B17 RV-B91 0.1011 RV-A02 RV-A49 0.05 3 RV-B70 RV-B91 0.1012 RV-A20 RV-A68 0.05 1 RV-C28 RV-Cpat24 0.0613 RV-A24 RV-A104 0.05 2 RV-C11 RV-C38 0.0814 RV-A36 RV-A89 0.06 3 RV-C41 RV-Cpat20 0.1015 RV-A40 RV-A85 0.06 4 RV-C5 RV-C38 0.1016 RV-A08 RV-A21 0.06 5 RV-C29 RV-C45 0.1017 RV-A21 RV-A95 0.06 6 RV-C4 RV-C49 0.1018 RV-A02 RV-A30 0.06 7 RV-C29 RV-Cpat17 0.1019 RV-A29 RV-A62 0.06 8 RV-C5 RV-C11 0.1020 RV-A49 RV-A74 0.06 9 RV-C32 RV-C39 0.1021 RV-A09 RV-A32 0.0622 RV-A02 RV-A74 0.0623 RV-A47 RV-A66 0.0624 RV-A56 RV-A66 0.0625 RV-A21 RV-A54 0.061 RV-B52 RV-B104 0.022 RV-B17 RV-B70 0.033 RV-B17 RV-B91 0.034 RV-B70 RV-B91 0.045 RV-B03 RV-B37 0.056 RV-B04 RV-B97 0.057 RV-B03 RV-B06 0.058 RV-B03 RV-B103 0.059 RV-B06 RV-B37 0.05
10 RV-B06 RV-B103 0.0511 RV-B48 RV-B104 0.0612 RV-B48 RV-B52 0.0613 RV-B03 RV-B14 0.0614 RV-B83 RV-B92 0.0615 RV-B14 RV-B37 0.0616 RV-B14 RV-B72 0.0617 RV-B14 RV-B102 0.061 RV-C7 RV-C21 0.042 RV-C32 RV-C39 0.053 RV-C3 RV-C6 0.054 RV-C1 RV-C3 0.055 RV-C3 RV-C10 0.066 RV-C1 RV-C6 0.067 RV-C11 RV-Cpat24 0.068 RV-C5 RV-C11 0.069 RV-C6 RV-C10 0.06
10 RV-C1 RV-C10 0.06
# #
Supplementary Table S2. Pairwise nucleotide sequence comparisons of RV-A, B and C types that have < 7% p-distances in partial 5' UTR and / or ≤ 10% p-distances in VP4/VP2 typing regions.
5'U
TR n
ucle
otid
e p-
dist
ance
Viru
s ty
pe1
23
45
67
89
1011
1213
1415
1617
1819
2021
2223
2425
2627
2829
3031
3233
3435
3637
3839
4041
4243
1R
V-A
160.
320.
200.
170.
190.
210.
280.
190.
230.
280.
280.
370.
200.
220.
35n/
an/
a0.
240.
380.
32n/
a0.
25n/
a0.
340.
380.
370.
330.
350.
160.
300.
290.
260.
190.
240.
210.
290.
290.
190.
200.
280.
220.
300.
372
RV
-B14
0.39
0.34
0.34
0.34
0.34
0.34
0.36
0.36
0.35
0.34
0.36
0.35
0.35
0.35
n/a
n/a
0.35
0.36
0.37
n/a
0.39
n/a
0.34
0.36
0.36
0.33
0.35
0.34
0.36
0.35
0.37
0.33
0.35
0.35
0.34
0.34
0.35
0.34
0.33
0.35
0.35
0.38
3R
V-C
10.
390.
410.
050.
060.
120.
300.
060.
270.
300.
310.
380.
120.
180.
37n/
an/
a0.
170.
360.
32n/
a0.
29n/
a0.
360.
360.
380.
350.
360.
070.
320.
300.
290.
050.
170.
130.
300.
290.
060.
010.
300.
180.
290.
354
RV
-C3
0.40
0.43
0.17
0.05
0.12
0.31
0.06
0.25
0.29
0.29
0.37
0.12
0.18
0.35
n/a
n/a
0.19
0.37
0.33
n/a
0.26
n/a
0.34
0.37
0.37
0.34
0.35
0.02
0.30
0.30
0.26
0.04
0.19
0.12
0.31
0.30
0.05
0.05
0.29
0.18
0.30
0.35
5R
V-C
60.
400.
440.
170.
120.
100.
290.
060.
250.
290.
290.
370.
100.
180.
36n/
an/
a0.
160.
370.
32n/
a0.
27n/
a0.
360.
370.
370.
350.
360.
070.
320.
290.
270.
030.
160.
110.
290.
280.
060.
050.
290.
180.
300.
366
RV
-C7
0.43
0.41
0.20
0.22
0.23
0.29
0.11
0.27
0.29
0.33
0.36
0.04
0.20
0.36
n/a
n/a
0.19
0.39
0.34
n/a
0.28
n/a
0.34
0.39
0.37
0.32
0.35
0.13
0.33
0.30
0.27
0.10
0.19
0.04
0.29
0.29
0.12
0.11
0.32
0.20
0.29
0.34
7R
V-C
80.
420.
420.
300.
250.
300.
280.
290.
230.
230.
190.
370.
290.
290.
34n/
an/
a0.
290.
360.
32n/
a0.
25n/
a0.
320.
360.
360.
330.
330.
300.
230.
230.
240.
290.
290.
280.
020.
020.
290.
300.
190.
290.
080.
358
RV
-C10
0.39
0.41
0.16
0.15
0.17
0.21
0.27
0.25
0.30
0.29
0.38
0.11
0.17
0.37
n/a
n/a
0.17
0.37
0.32
n/a
0.25
n/a
0.36
0.37
0.39
0.35
0.37
0.07
0.30
0.30
0.25
0.06
0.17
0.12
0.28
0.28
0.01
0.06
0.28
0.17
0.29
0.34
9R
V-C
110.
390.
390.
330.
320.
330.
300.
310.
320.
230.
240.
350.
270.
270.
36n/
an/
a0.
270.
330.
28n/
a0.
06n/
a0.
330.
340.
360.
340.
340.
250.
230.
250.
060.
250.
270.
270.
220.
220.
250.
270.
240.
270.
240.
3510
RV
-C12
0.42
0.40
0.26
0.29
0.31
0.28
0.24
0.29
0.31
0.22
0.33
0.29
0.29
0.32
n/a
n/a
0.29
0.36
0.32
n/a
0.25
n/a
0.30
0.37
0.33
0.29
0.31
0.28
0.08
0.03
0.24
0.28
0.30
0.28
0.23
0.23
0.30
0.29
0.21
0.29
0.26
0.37
11R
V-C
170.
420.
430.
270.
250.
260.
290.
200.
270.
310.
240.
360.
310.
280.
36n/
an/
a0.
300.
340.
31n/
a0.
26n/
a0.
360.
340.
370.
330.
360.
300.
220.
230.
250.
290.
310.
300.
190.
180.
290.
310.
000.
280.
190.
3712
RV
-C20
0.41
0.42
0.33
0.31
0.30
0.32
0.31
0.33
0.19
0.31
0.31
0.35
0.38
0.22
n/a
n/a
0.38
0.24
0.25
n/a
0.37
n/a
0.20
0.25
0.04
0.21
0.20
0.37
0.35
0.34
0.36
0.38
0.39
0.34
0.37
0.37
0.38
0.38
0.36
0.38
0.38
0.32
13R
V-C
210.
410.
450.
230.
210.
210.
150.
290.
230.
320.
290.
290.
340.
190.
33n/
an/
a0.
190.
380.
33n/
a0.
27n/
a0.
330.
390.
370.
310.
340.
130.
320.
290.
260.
100.
190.
010.
290.
290.
110.
120.
310.
190.
300.
3414
RV
-C32
0.39
0.43
0.22
0.24
0.25
0.20
0.29
0.23
0.31
0.27
0.27
0.34
0.19
0.38
n/a
n/a
0.05
0.36
0.32
n/a
0.28
n/a
0.36
0.37
0.38
0.36
0.37
0.18
0.29
0.30
0.29
0.17
0.04
0.20
0.29
0.29
0.17
0.19
0.28
0.00
0.27
0.33
15R
V-C
330.
410.
400.
310.
300.
310.
300.
240.
300.
280.
250.
270.
260.
280.
26n/
an/
a0.
360.
230.
24n/
a0.
38n/
a0.
040.
230.
200.
110.
010.
350.
330.
320.
370.
360.
380.
330.
340.
340.
370.
370.
360.
380.
350.
3216
RV
-C34
0.41
0.44
0.35
0.29
0.30
0.34
0.32
0.34
0.18
0.30
0.30
0.11
0.33
0.34
0.27
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
17R
V-C
370.
400.
400.
270.
310.
270.
280.
300.
250.
290.
260.
290.
280.
280.
250.
250.
29n/
an/
an/
an/
an/
an/
an/
an/
an/
an/
an/
an/
an/
an/
an/
an/
an/
an/
an/
an/
an/
an/
an/
an/
an/
an/
a18
RV
-C39
0.41
0.42
0.20
0.24
0.24
0.23
0.29
0.24
0.32
0.29
0.26
0.34
0.21
0.10
0.26
0.34
0.25
0.36
0.33
n/a
0.28
n/a
0.36
0.37
0.38
0.36
0.35
0.19
0.28
0.29
0.28
0.17
0.01
0.19
0.28
0.28
0.17
0.17
0.29
0.05
0.27
0.35
19R
V-C
51_J
F317
015
0.37
0.40
0.27
0.25
0.26
0.26
0.29
0.23
0.28
0.24
0.25
0.24
0.28
0.25
0.24
0.26
0.15
0.25
0.10
n/a
0.35
n/a
0.21
0.01
0.24
0.21
0.22
0.37
0.38
0.38
0.34
0.37
0.37
0.37
0.36
0.35
0.37
0.37
0.33
0.36
0.33
0.35
20R
V-C
51_J
X29
1115
0.39
0.42
0.28
0.25
0.28
0.26
0.27
0.27
0.31
0.24
0.23
0.25
0.27
0.27
0.22
0.27
0.24
0.26
0.14
n/a
0.27
n/a
0.23
0.11
0.25
0.23
0.23
0.32
0.35
0.35
0.27
0.32
0.34
0.32
0.32
0.32
0.32
0.33
0.30
0.32
0.30
0.33
21R
V-C
pat2
20.
420.
420.
340.
300.
280.
290.
270.
290.
300.
280.
250.
240.
290.
290.
130.
250.
230.
270.
210.
21n/
an/
an/
an/
an/
an/
an/
an/
an/
an/
an/
an/
an/
an/
an/
an/
an/
an/
an/
an/
an/
an/
a22
RV
-Cpa
t24
0.41
0.41
0.25
0.25
0.25
0.23
0.19
0.30
0.32
0.27
0.19
0.29
0.25
0.27
0.26
0.31
0.29
0.27
0.26
0.25
0.25
n/a
0.36
0.35
0.37
0.35
0.36
0.25
0.26
0.27
0.02
0.27
0.29
0.27
0.25
0.25
0.25
0.29
0.25
0.28
0.23
0.35
23R
V-C
pat2
80.
400.
400.
260.
260.
270.
280.
130.
280.
310.
220.
170.
290.
290.
290.
250.
290.
270.
270.
270.
240.
270.
15n/
an/
an/
an/
an/
an/
an/
an/
an/
an/
an/
an/
an/
an/
an/
an/
an/
an/
an/
an/
a24
W21
_(R
V-C
pat2
2)0.
430.
420.
330.
290.
280.
290.
260.
290.
300.
270.
250.
250.
280.
280.
120.
240.
230.
270.
210.
210.
020.
250.
270.
220.
200.
110.
040.
340.
320.
310.
350.
350.
370.
320.
330.
320.
360.
360.
360.
360.
330.
3225
W32
_(R
V-C
37)
0.39
0.41
0.26
0.30
0.27
0.28
0.30
0.24
0.29
0.26
0.27
0.29
0.27
0.25
0.23
0.29
0.02
0.24
0.14
0.23
0.22
0.29
0.25
0.22
0.24
0.22
0.22
0.37
0.39
0.39
0.34
0.38
0.37
0.37
0.36
0.36
0.37
0.37
0.34
0.37
0.33
0.36
26W
50_(
RV
-C34
)0.
420.
440.
340.
310.
280.
340.
340.
330.
170.
320.
300.
100.
330.
330.
260.
050.
280.
330.
270.
290.
240.
290.
310.
240.
270.
200.
190.
370.
350.
340.
370.
370.
400.
350.
360.
360.
380.
390.
370.
380.
370.
3127
W51
_(R
V-C
pat2
2)0.
420.
400.
320.
280.
290.
300.
260.
300.
310.
280.
260.
270.
280.
290.
130.
250.
230.
270.
230.
230.
050.
250.
270.
040.
230.
260.
120.
340.
320.
310.
330.
340.
370.
290.
320.
310.
350.
350.
320.
360.
320.
3228
W54
_(R
V-C
33)
0.42
0.40
0.31
0.29
0.30
0.29
0.24
0.30
0.29
0.26
0.26
0.25
0.28
0.26
0.00
0.26
0.25
0.26
0.24
0.21
0.13
0.26
0.25
0.12
0.24
0.26
0.12
0.35
0.32
0.31
0.35
0.36
0.37
0.33
0.33
0.32
0.36
0.36
0.35
0.37
0.33
0.31
29W
02_(
RV
-C3)
0.39
0.42
0.15
0.02
0.13
0.20
0.27
0.16
0.33
0.29
0.26
0.31
0.20
0.22
0.29
0.30
0.29
0.23
0.26
0.26
0.30
0.23
0.26
0.29
0.29
0.32
0.28
0.29
0.30
0.30
0.26
0.06
0.18
0.13
0.30
0.29
0.06
0.07
0.29
0.18
0.28
0.34
30W
04_(
RV
-C44
)0.
380.
390.
250.
250.
290.
280.
190.
260.
290.
160.
230.
310.
290.
270.
250.
290.
270.
270.
260.
250.
230.
240.
220.
220.
270.
310.
210.
250.
250.
060.
250.
300.
300.
310.
220.
230.
310.
320.
220.
290.
260.
3831
W09
_(R
V-C
12)
0.42
0.40
0.26
0.29
0.29
0.28
0.22
0.28
0.32
0.06
0.23
0.31
0.30
0.29
0.27
0.31
0.25
0.29
0.26
0.25
0.27
0.25
0.20
0.27
0.25
0.33
0.27
0.28
0.28
0.17
0.27
0.29
0.30
0.28
0.23
0.23
0.31
0.30
0.22
0.30
0.27
0.37
32W
23_(
RV
-C11
)0.
390.
390.
330.
320.
330.
300.
300.
310.
040.
300.
310.
180.
320.
300.
250.
170.
270.
320.
270.
310.
290.
310.
290.
280.
270.
170.
280.
250.
330.
290.
310.
270.
280.
260.
240.
240.
250.
290.
250.
290.
230.
3333
W24
_(R
V-C
6)0.
400.
440.
150.
120.
040.
230.
270.
170.
340.
300.
250.
300.
220.
260.
310.
300.
280.
250.
260.
270.
290.
230.
240.
290.
280.
300.
280.
300.
130.
280.
270.
340.
170.
100.
290.
280.
060.
050.
290.
170.
290.
3534
W27
_(R
V-C
39)
0.40
0.43
0.21
0.24
0.25
0.23
0.29
0.25
0.32
0.29
0.27
0.34
0.19
0.09
0.25
0.33
0.25
0.03
0.24
0.25
0.27
0.27
0.27
0.27
0.23
0.33
0.27
0.25
0.23
0.28
0.28
0.32
0.26
0.19
0.29
0.29
0.17
0.17
0.30
0.04
0.28
0.34
35W
29_(
RV
-C21
)0.
420.
440.
220.
190.
200.
120.
270.
210.
310.
310.
270.
330.
070.
210.
280.
320.
270.
210.
250.
260.
270.
250.
280.
260.
270.
310.
270.
280.
180.
250.
310.
310.
200.
200.
280.
280.
120.
120.
300.
200.
280.
3336
W47
_(R
V-C
pat2
8)0.
400.
390.
250.
260.
280.
280.
130.
280.
310.
230.
180.
300.
290.
290.
250.
290.
270.
270.
270.
250.
270.
150.
010.
270.
260.
300.
270.
260.
270.
210.
200.
300.
250.
270.
290.
010.
290.
300.
190.
290.
070.
3537
W47
-R95
4_(R
V-C
8)0.
400.
420.
270.
250.
290.
260.
060.
270.
300.
230.
190.
290.
300.
300.
250.
310.
290.
280.
270.
240.
250.
190.
120.
260.
290.
320.
270.
250.
260.
180.
210.
300.
270.
290.
280.
120.
290.
290.
180.
290.
070.
3538
W55
_(R
V-C
10)
0.38
0.42
0.16
0.15
0.15
0.22
0.28
0.03
0.32
0.27
0.27
0.33
0.23
0.23
0.29
0.33
0.25
0.23
0.22
0.28
0.29
0.29
0.28
0.29
0.23
0.32
0.30
0.30
0.16
0.26
0.29
0.31
0.16
0.24
0.22
0.28
0.27
0.06
0.28
0.17
0.28
0.34
39W
56_(
RV
-C1)
0.38
0.42
0.04
0.15
0.16
0.21
0.28
0.16
0.33
0.28
0.27
0.32
0.23
0.21
0.29
0.34
0.28
0.19
0.27
0.28
0.32
0.23
0.26
0.31
0.27
0.33
0.31
0.29
0.14
0.25
0.28
0.33
0.14
0.21
0.22
0.27
0.26
0.15
0.30
0.19
0.30
0.36
40W
57_(
RV
-C17
)0.
430.
430.
270.
250.
270.
290.
200.
270.
310.
250.
020.
310.
280.
270.
260.
310.
290.
270.
260.
230.
230.
200.
190.
230.
270.
310.
250.
250.
260.
230.
230.
310.
250.
280.
270.
190.
190.
260.
260.
280.
190.
3641
W58
_(R
V-C
32)
0.40
0.42
0.22
0.25
0.24
0.19
0.29
0.24
0.31
0.27
0.27
0.35
0.19
0.02
0.26
0.34
0.25
0.12
0.27
0.28
0.28
0.27
0.29
0.28
0.25
0.34
0.29
0.26
0.23
0.26
0.28
0.30
0.25
0.10
0.21
0.29
0.31
0.24
0.22
0.28
0.27
0.33
42W
59_(
RV
-Cpa
t28)
0.40
0.38
0.25
0.26
0.27
0.28
0.14
0.27
0.31
0.23
0.18
0.29
0.29
0.28
0.25
0.29
0.27
0.27
0.27
0.25
0.27
0.16
0.02
0.28
0.26
0.30
0.27
0.25
0.26
0.22
0.21
0.30
0.25
0.28
0.28
0.02
0.12
0.28
0.26
0.19
0.28
0.35
43P
V-3
l_K
0139
20.
410.
380.
400.
380.
380.
390.
380.
400.
410.
370.
370.
380.
390.
400.
390.
380.
380.
400.
370.
370.
350.
370.
360.
350.
380.
380.
370.
390.
380.
350.
340.
410.
380.
400.
380.
360.
380.
400.
410.
370.
400.
36VP
4/VP
2 nu
cleo
tide
p-di
stan
ce
Supp
lem
enta
ry T
able
S3.
. Pai
rwis
e nu
cleo
tide
sequ
ence
com
paris
ons
of s
elec
ted
RV
-A, B
and
C re
fere
nce
type
s an
d W
type
s th
at h
ave ≤
7% p
-dis
tanc
es in
par
tial 5
' UTR
and
≤ 1
0% p
-dis
tanc
es in
VP4
/VP2
typ
ing
regi
ons
(sho
wn
in
bold
).
W type (5'UTR)
RV-C type* (VP4/VP2)
5'UTRstnemmoCepytbus
W01 RV-C36 CcW02 RV-C3 CaW03 RV-C14 CcW04 RV-C44 CaW05 RV-C25 CaW06 RV-A103 n/aW07 RV-C13 CaW08 RV-C18 CaW09 RV-C12 CaW10 RV-C15 CaW11 RV-C40 CaW12 RV-C02 CaW13 RV-C45 CcW14 n/a n/a Putative artificial recombinant of RV-A68 and RV-C3W15 RV-C22 CaW16 RV-C42 CaW17 RV-C23 CaW18 RV-Cpat19 CcW19 RV-C46 CcW20 RV-C28 CaW21 RV-Cpat22 Cc Putative recombinant of RV-C33 (5'UTR) and RV-Cpat22 (VP4/VP2)W22 RV-A n/a Putative new RV-A type, 98% identity with FJ950948 (5'UTR) and 91% with KF034014 (VP4/VP2)W23 RV-C11 CaW24 RV-C6 CaW25 RV-C41 Ca Misidentified as RV-Cpat20 in Lee et al., (2012)W26 RV-Cpat10 CcW27 RV-C39 CaW28 RV-A101 n/aW29 RV-C21 CaW30 RV-C31 CaW31 RV-C09 CcW32 RV-C37 Cc Putative recombinant of RV-C51 (5'UTR) and RV-C37 (VP4/VP2)W33 RV-C49 CaW34 RV-C24 CaW35 RV-Cpat17 CcW36 RV-C43 CaW37 RV-C26 CcW38 RV-C16 CaW39 RV-C47 CaW40 RV-C35 CcW41 RV-C19 CcW42 RV-C30 CaW43 RV-C50 CcW44 RV-C27 CcW45 RV-C29 CcW46 RV-C05 CaW47 RV-Cpat28 Ca Putative recombinant of RV-C8 (5'UTR) and RV-Cpat28 (VP4-2)W47-R954 RV-C8 CaW48 RV-A n/a Putative new RV-A type, 99% identity with GQ223185 (5'UTR) and 98% with GQ223154 (VP4/VP2)W49 RV-A n/a Putative new RV-A type, 99% identity with GU933105 (5'UTR) and 99% with JX863815 (VP4/VP2)W50 RV-C34 Cc Putative recombinant of RV-C20 (5'UTR) and RV-C34 (VP4/VP2)W51 RV-Cpat22 CcW52 RV-Cpat21 CcW53 RV-A106 n/aW54 RV-C33 CcW55 RV-C10 CaW56 RV-C1 CaW57 RV-C17 CaW58 RV-C32 CaW59 RV-Cpat28 Ca
* RV-C types correspond to those proposed by Simmonds et al., (2010) and McIntyre et al., (2013).Putative recombinant W types are underlined, novel types are shown in bold, RV-A types are shown in red
Supplementary Table S4. Updated conversion of W types (5’UTR based classification) tocorresponding RV-C or novel RV-A types (VP4/VP2 based classification).
Supplementary methods 1. Total RNA extraction from clinical samples (nasal lavage fluid or sputum)
1. Make a stock of carrier mix (10 µl) for each sample:
a. 0.5 µl human DNA (100 ng/µl; Clontech, 639401), total = 50 ng b. 4 µl glycogen (5 µg/µl; Applied Biosystems, 9510), total = 20 µg c. 1 µl glycoblue (15 µg/µl, Applied Biosystems, 9515), total = 15 µg d. 4.5 µl PBS
2. Prepare 5× NA Extraction Buffer (500 ml): 125 ml 2M Tris, pH 7.5 -> 500 mM 150 ml 5M NaCl -> 1500 mM 5 ml 0.5M EDTA -> 5mM 220 ml ddH2O
3. To each 350 µl nasal sample (adjust volume with PBS if necessary),
a. Add 10 µl carrier mix and b. 25 µl 5×NA extraction buffer c. 0.75 mL Trizol LS (Invitrogen, 102960-28)
4. Mix well (shake 20 times) and then vortex for 10 minutes in thermomixer at max
speed at room temp.
5. Add 230 µl of chloroform (Sigma, C2432) to each sample.
6. Mix well (shake 20 times) and then vortex for 5 minutes in thermomixer at max speed at room temp.
7. Centrifuge at max speed (≥10,000 rpm) for 5 minutes at room temperature.
8. Add 0.6 mL µl isopropanol (Sigma, I9516; RNase-free) into a new tube.
9. Transfer the upper aqueous layer (~ 700 µl) from the sample tube to the
isopropanol tube. Try to avoid DNA carryover.
10. Mix well (shake 20 times), then incubate at room temp for ≥ 1 hour for RNA precipitation.
11. Centrifuge at max speed for 12 minutes at room temperature to pellet RNA
precipitate.
12. Remove supernatant by pipetting.
13. Add 0.7 mL of 75% ethanol to each tube and then mix well and vortex for 3 sec.
14. Centrifuge at max speed for 5 minutes at room temperature.
15. Remove supernatant by pipetting.
16. Air-dry pellets for ≥ 15 minutes at room temp.
17. Add 22 µl of Nuclease-Free water to pellet. Vortex vigorously to dissolve RNA.
18. Store RNA in -80°C freezer or proceed with RT reaction.
2. cDNA synthesis (RT): Reagents: High-Capacity cDNA Reverse Transcription Kit with RNase Inhibitor, 1000 reactions (Applied Biosystems, 4374967). This kit contains 10× RT buffer, 25× dNTP mix, 10× RT random primers, MultiScribe RT enzyme and RNase inhibitor. Procedure: 1. Prepare RT master mix: For 1 reaction: 4 µl 10× RT buffer 1.6 µl 25× dNTP mix 4 µl 10× RT random primers 2 µl MultiScribe RT 2 µl RNase inhibitor 6.4 µl water 2. Aliquot 20 µl of RT master mix into each tube. 3. Add 20 µl of RNA into tubes with master mix, pipet up and down 2 times to mix, and centrifuge briefly. Run the RT reaction. Reaction conditions: 25°C, 10 min, 37°C 120 min, 85°C, 5 min.